Boston Financial Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$955K Hold
3,657
0.03% 197
2024
Q3
$851K Hold
3,657
0.03% 206
2024
Q2
$738K Buy
3,657
+3
+0.1% +$541 0.02% 216
2024
Q1
$626K Hold
3,654
0.02% 232
2023
Q4
$793K Hold
3,654
0.03% 207
2023
Q3
$583K Sell
3,654
-10
-0.3% -$2.24K 0.02% 216
2023
Q2
$1.06M Buy
3,664
+2
+0.1% +$607 0.04% 181
2023
Q1
$1.17M Sell
3,662
-4
-0.1% -$1.19K 0.05% 165
2022
Q4
$1.08M Hold
3,666
0.04% 171
2022
Q3
$841K Sell
3,666
-496
-12% -$124K 0.04% 178
2022
Q2
$907K Buy
4,162
+8
+0.2% +$1.82K 0.04% 164
2022
Q1
$1.11M Buy
4,154
+3,114
+299% +$764K 0.04% 155
2021
Q4
$277K Buy
1,040
+1
+0.1% +$290 0.01% 236
2021
Q3
$295K Hold
1,039
0.01% 223
2021
Q2
$285K Hold
1,039
0.01% 218
2021
Q1
$271K Sell
1,039
-2,000
-66% -$536K 0.01% 211
2020
Q4
$777K Hold
3,039
0.04% 138
2020
Q3
$719K Buy
+3,039
New +$640K 0.04% 140

Other funds holding PODD

Boston Financial Management's PODD Position: Q4 2024 in Review

Boston Financial Management held its Insulet (PODD) position steady in Q4 2024 at 3,657 shares worth $955K. The position accounts for 0.03% of the portfolio, ranked #197.

Boston Financial Management first reported a position in PODD in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.17M in Q1 2023. 683 funds tracked by Wall St. Rank hold PODD as of Q4 2024.

  • Boston Financial Management held 3,657 shares of Insulet worth $955K as of Q4 2024.
  • Boston Financial Management left its Insulet share count unchanged in Q4 2024.
  • Insulet made up 0.03% of Boston Financial Management's portfolio in Q4 2024, its #197 holding.
  • Boston Financial Management first reported a position in Insulet in Q3 2020 and has held it in 18 quarters since.
  • Boston Financial Management's Insulet position peaked at $1.17M in Q1 2023.
  • 683 funds tracked by Wall St. Rank held Insulet as of Q4 2024.

Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.